Servicios de Nefrologia adultos.
Nefrologia Pediatrica.
Clin J Am Soc Nephrol. 2018 Feb 7;13(2):258-264. doi: 10.2215/CJN.02530317. Epub 2017 Nov 16.
The prognostic value of mesangial C4d deposits in IgA nephropathy has been analyzed in patients with reduced GFR but has not been analyzed in those with normal kidney function. The main objective of the study was to analyze the prognostic value of C4d deposits and association with response to treatment in patients with IgA nephropathy and normal GFR.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This retrospective cohort study included 190 patients with idiopathic IgA nephropathy diagnosed by kidney biopsy between 1988 and 2005. The patients had GFR≥80 ml/min per 1.73 m at the time of diagnosis, and they had a paraffin-embedded kidney biopsy with eight glomeruli available.
In total, 170 (89%) and 20 (11%) patients were >18 and <18 years old, respectively; median (interquartile range) follow-up was 15 (12-22) years. Mesangial C4d deposit prevalence was 20% (38 of 190). At diagnosis, C4d-positive versus -negative patients had higher protein-to-creatinine ratio (median [interquartile range]: 1.94 g/g [0.9-3.1] versus 1.45 g/g [0.9-2.2]; =0.04). During follow-up, C4d-positive patients showed a higher number of nephritic flares (median [range]: 1.4 [0-5] versus 0.9 [0-2]; =0.04), had a higher protein-to-creatinine ratio (median [interquartile range]: 1.32 g/g [0.7-1.7] versus 0.89 g/g [0.1-1.3]; <0.01), were more prone to receive repeated treatment with corticosteroids (45% versus 24%; <0.01), and showed a larger reduction in eGFR (-1.6 versus -0.8 ml/min per 1.73 m per year; =0.04). Furthermore, the presence of mesangial C4d deposits was an independent predictor of long-term kidney survival.
C4d deposits may be one of the earliest poor prognostic variables available for patients with idiopathic IgA nephropathy and normal kidney function at the time of diagnosis. However, Cd4 deposits alone are not associated with the response to angiotensin blockers or corticosteroid treatment.
已有研究分析了肾小球滤过率(GFR)降低的 IgA 肾病患者系膜区 C4d 沉积的预后价值,但尚未分析 GFR 正常的患者。本研究的主要目的是分析 C4d 沉积在 GFR 正常的 IgA 肾病患者中的预后价值及其与治疗反应的相关性。
设计、地点、参与者和测量方法:这是一项回顾性队列研究,纳入了 190 例 1988 年至 2005 年间经肾活检诊断的特发性 IgA 肾病患者。这些患者在诊断时的 GFR≥80ml/min/1.73m2,且均有可供评估的 8 个肾小球的石蜡包埋肾活检。
190 例患者中,170 例(89%)和 20 例(11%)患者年龄分别大于 18 岁和小于 18 岁;中位(四分位间距)随访时间为 15(1222)年。系膜区 C4d 沉积的发生率为 20%(38/190)。在诊断时,C4d 阳性患者的蛋白尿/肌酐比值更高(中位数[四分位间距]:1.94g/g[0.93.1]比 1.45g/g[0.92.2];=0.04)。在随访期间,C4d 阳性患者的肾炎发作次数更多(中位数[范围]:1.4[05]次比 0.9[02]次;=0.04),蛋白尿/肌酐比值更高(中位数[四分位间距]:1.32g/g[0.71.7]比 0.89g/g[0.1~1.3];<0.01),更倾向于接受重复的皮质激素治疗(45%比 24%;<0.01),估算肾小球滤过率(eGFR)下降幅度更大(-1.6 比-0.8ml/min/1.73m2/年;=0.04)。此外,系膜区 C4d 沉积的存在是 GFR 正常的特发性 IgA 肾病患者长期肾脏生存的独立预测因子。
C4d 沉积可能是特发性 IgA 肾病患者在诊断时 GFR 正常的最早的不良预后变量之一。然而,C4d 沉积本身与血管紧张素受体阻滞剂或皮质激素治疗的反应无关。